User talk:Sherief abd-elsalam

Hello and welcome to Wikipedia. Thank you for your contributions. I hope you like the place and decide to stay. The following links will help you begin editing on Wikipedia:
 * Welcome!
 * The five pillars of Wikipedia
 * How to edit a page
 * Editing tutorial
 * Picture tutorial
 * How to write a great article
 * Naming conventions
 * Manual of Style


 * Please bear these points in mind while editing Wikipedia:
 * Respect copyrights – do not copy and paste text or images directly from other websites.
 * Maintain a neutral point of view – this is one of Wikipedia's core policies.
 * Take particular care while adding biographical material about a living person to any Wikipedia page and follow Wikipedia's Biography of Living Persons policy. Particularly, controversial and negative statements should be referenced with multiple reliable sources.
 * No edit warring or sock puppetry.
 * If you are testing, please use the Sandbox to [ do so].
 * Do not add troublesome content to any article, such as: copyrighted text, libel, advertising or promotional messages, and text that is not related to an article's subject. Deliberately adding such content or otherwise editing articles maliciously is considered vandalism; doing so will result in your account or IP being blocked from editing.
 * Do not use talk pages as discussion or forum pages as Wikipedia is not a forum.

The Wikipedia tutorial is a good place to start learning about Wikipedia. If you have any questions, see the help pages, add a question to the village pump or ask me on my talk page. By the way, you can sign your name on Talk and discussion pages using four tildes, like this: &#126;&#126;&#126;&#126; (the software will replace them with your signature and the date). Again, welcome!

Sleep disorders cirrhosis abd-elsalam
This is an automated message from CorenSearchBot. I have performed a web search with the contents of Sleep disorders cirrhosis abd-elsalam, and it appears to include material copied directly from http://paper.researchbib.com/view/paper/67817.

It is possible that the bot was mistaken and found similarity where none actually exists. If that is the case, you can remove the tag from the article. The article will be reviewed to determine if there are any copyright issues.

If substantial content is duplicated and it is not public domain or available under a compatible license, it will be deleted. For legal reasons, we cannot accept copyrighted text or images borrowed from other web sites or printed material. You may use such publications as a source of information, but not as a source of sentences. See our copyright policy for further details. (If you own the copyright to the previously published content and wish to donate it, see Donating copyrighted materials for the procedure.) CorenSearchBot (talk) 09:40, 26 March 2016 (UTC)

Speedy deletion nomination of Sleep disorders cirrhosis abd-elsalam


A tag has been placed on Sleep disorders cirrhosis abd-elsalam requesting that it be speedily deleted from Wikipedia. This has been done under section G12 of the criteria for speedy deletion, because the article or image appears to be a clear copyright infringement. This article or image appears to be a direct copy from http://paper.researchbib.com/view/paper/67817. For legal reasons, we cannot accept copyrighted text or images borrowed from other web sites or printed material, and as a consequence, your addition will most likely be deleted. You may use external websites or other printed material as a source of information, but not as a source of sentences. This part is crucial: say it in your own words. Wikipedia takes copyright violations very seriously and persistent violators will be blocked from editing.

If the external website or image belongs to you, and you want to allow Wikipedia to use the text or image — which means allowing other people to modify it — then you must verify that externally by one of the processes explained at Donating copyrighted materials. If you are not the owner of the external website or image but have permission from that owner, see Requesting copyright permission. You might want to look at Wikipedia's policies and guidelines for more details, or ask a question here.

If you think this page should not be deleted for this reason, you may contest the nomination by visiting the page and clicking the button labelled "Contest this speedy deletion". This will give you the opportunity to explain why you believe the page should not be deleted. However, be aware that once a page is tagged for speedy deletion, it may be removed without delay. Please do not remove the speedy deletion tag from the page yourself, but do not hesitate to add information in line with Wikipedia's policies and guidelines. —Largo Plazo (talk) 09:49, 26 March 2016 (UTC)

March 2016
Please do not add promotional material to Wikipedia. While objective prose about beliefs, organisations, people, products or services is acceptable, Wikipedia is not intended to be a vehicle for soapboxing, advertising or promotion. As I said earlier, this isn't a vehicle for drawing attention to your paper. —Largo Plazo (talk) 03:37, 27 March 2016 (UTC)

Identification of Ascitic Fluid Bacterial Pathogens in Spontaneous Bacterial Peritonitis in Nile Delta and Its Impact on Clinical Outcome of these Patients
REFERENCES 1. Tandon P, Garcia-Tsao G. Bacterial infections, sepsis, and multiorgan failure in cirrhosis. Semin Liver Dis. 2008;28:26-42. 2. Appenrodt B, Lehmann LE, Thyssen L, Gentemann M, Rabe C, Molitor E, et al. Is detection of bacterial DNA in ascitic fluid of clinical relevance? Eur J Gastroenterol Hepatol. 2010;22:1487–94. 3. Barreales M, Fernandez I. Spontaneous bacterial peritonitis. Rev Esp Enferm Dig. 2011;103:255–63. 4. Elfert A, Abo Ali L, Soliman S, Ibrahim S, Abd-Elsalam S. Randomized-controlled trial of rifaximin versus norfloxacin for secondary prophylaxis of spontaneous bacterial peritonitis. Eur J Gastroenterol Hepatol; 2016. (In press). 5. Fagan KJ, Rogers GB, Melino M, Arthur DM, Costello ME, Morrison M, et al. Ascites bacterial burden and immune cell profile are associated with poor clinical outcomes in the absence of overt infection. Plos One. 2015;10(3):e0120642. 6. Soriano G, Esparcia O, Montemayor M, Guarner-Argente C, Pericas R, Torras X, et al. Bacterial DNA in the diagnosis of spontaneous bacterial peritonitis. Aliment Pharmacol Ther. 2011;33:275–84. 7. Sort P, Navasa M, Arroyo V, VAldeguer X, Planas R, Ruiz-del-Arbol L, et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med. 1999;341(6):403-9. 8. Wiest R, Krag A, Gerbes A. Spontaneous bacterial peritonitis: Recent guidelines and beyond. Gut. 2012;61:297-310. 9. Abd-Elsalam S, Soliman H, Elkhalawany W, Haidy Khalil, Samah Soliman, Eslam Ismail, et al. Is spontaneous bacterial peritonitis still responding to third generation cephalosporins?: A single centre experience. Int J Curr Microbiol App Sci. 2016;5(5):392-9. Khalil et al.; BMRJ, 17(4): 1-6, 2016; Article no.BMRJ.29869 6 10. Fernandez J, Acevedo J, Castro M, Garcia O, de Lope CR, Roca D, et al. Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: A prospective study. Hepatology. 2012;55: 1551-61. 11. Sheikhbahaei S, Abdollahi A, Hafezi-Nejad N, Zare E. Patterns of antimicrobial resistance in the causative organisms of spontaneous bacterial peritonitis. Int J Hepatol. 2014;2014: 917856. 12. Guarner C, Soriano G. Spontaneous bacterial peritonitis. Semin Liver Dis. 1997; 17:203–17. 13. Alexopoulou A, Papadopoulos N, Eliopoulos DG, Alexaki A, Tsiriga A, Toutouza M, et al. Increasing frequency of gram-positive cocci and gram-negative multidrug-resistant bacteria in spontaneous bacterial peritonitis. Liver Int. 2013;33:975–81. 14. Lutz P, Nischalke HD, Strassburg CP, Spengler U. Spontaneous bacterial peritonitis: The clinical challenge of a leaky gut and a cirrhotic liver. World J Hepatol. 2015;27;7(3):304-14. 15. Bibi S, Ahmed W, Arif A, Khan F, Alam SE. Clinical, laboratory and bacterial profile of spontaneous bacterial peritonitis in chronic liver disease patients. J Coll Physicians Surg Pak. 2015;25:95-9. 16. European Association for the Study of the Liver. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol. 2010;53: 397-417. 17. Sajjad M, Khan ZA, Khan MS. Ascitic Fluid culture in cirrhotic patients with spontaneous bacterial peritonitis. J Coll Physicians Surg Pak. 2016;26:658-61. 18. Cholongitas E, Papatheodoridis GV, Lahanas A, Xanthaki A, Kontou- Kastellanou C, Archimandritis AJ. Increasing frequency of Gram-positive bacteria in spontaneous bacterial peritonitis. Liver Int. 2005;25:57–61. 19. Fernandez J, Acevedo J, Castro M, Garcia O, de Lope CR, Roca D, et al. Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: A prospective study. Hepatology. 2012; 55:1551–61. 20. Gou Y, Zhang F, Liang Z, Bai X, Pan L, Wang W, et al. Pathogens change in spontaneous bacterial peritonitis patients with cirrhosis. African J Microbiol Res. 2011;5(1):1-7. 21. Hardick J, Won H, Jeng K, Hsieh YH, Gaydos CA, Rothman RE, et al. Identification of bacterial pathogens in ascitic fluids from patients with suspected spontaneous bacterial peritonitis by use of broad-range PCR (16S PCR) coupled with high-resolution melt analysis. J Clin Microbiol. 2012;50(7):2428–32. 22. Alexopoulou A, Vasilieva L, Agiasotelli D, Siranidi K, Pouriki S, Tsiriga A, et al. Extensively drug-resistant bacteria are an independent predictive factor of mortality in 130 patients with spontaneous bacterial peritonitis or spontaneous bacteremia. World J Gastroenterol. 2016;22(15):4049- 56. 23. Iqbal S, Imran N, Alam N, et al. Incidence of spontaneous bacterial peritonitis in liver cirrhosis, the causative organisms and antibiotic sensitivity. JPMI. 2004;18:614-9. 24. Haider I, Ahmad I, Rashid A, Bashir H. Causative organisms and their drug sensitivity pattern in ascetic fluid of cirrhotic patients with spontaneous bacterial peritonitis. JPMI. 2008;22:333-9. 25. Navasa M, Fernández J, Rodés J, et al. Bacterial infections in liver cirrhosis. Ital J Gastroenterol Hepatol. 1999;31:616-25. 26. Runyon BA. AASLD Practice Guidelines Committee. Management of adult patients with ascites due to cirrhosis: an update. Hepatology. 2009;49:2087-107. 27. Jalan R, Fernández J, Wiest R, Schnabl B, Moreau R, Angeli P, et al. Bacterial infections in cirrhosis: A position statement based on the EASL Special Conference 2013. J Hepatol. 2014;60:1310-24. _________________________________________________________________________________

== Nonalcoholic fatty liver disease in patients with acute ischemic stroke is associated with more severe stroke and worse outcome.Sherief abd-elsalam (talk) 10:08, 20 August 2017 (UTC) https://www.ncbi.nlm.nih.gov/pubmed/28579247 ==

BACKGROUND: There is a paucity of data regarding the association between nonalcoholic fatty liver disease (NAFLD) and acute ischemic stroke. Stroke is largely preventable, so that knowledge of risk factors is essential to achieve reductions in the stroke rate and resulting disease burden. OBJECTIVE: The aim of the present study was to evaluate the prognostic value of NAFLD on stroke severity and outcome. METHODS: We prospectively studied 200 patients who were admitted with acute ischemic stroke between September 2013 and August 2015. Demographic and vascular risk factors were detailed for all subjects. The severity of stroke was assessed with National Institutes of Health Stroke Scale score at admission. NAFLD was defined as serum alanine aminotransferase and/or aspartate aminotransferase levels above the upper limit of normal in the absence of other causes of elevated aminotransferase levels. The outcome was assessed with the modified Rankin scale score at discharge. RESULTS: NAFLD was found in 42.5% of the study population. The prevalence of diabetes was significantly higher among patients with NAFLD than those without NAFLD (P = .001). Waist circumference was significantly higher among patients with NAFLD than those without NAFLD (P < .05). Patients with NAFLD had significantly higher glucose, Triglycerides, Low density lipoprotein, serum alanine aminotransferase and aspartate aminotransferase than those without NAFLD (P < .05 for each comparison). National Institutes of Health Stroke Scale score at admission and modified Rankin scale score at discharge were significantly higher in patients with NAFLD than those without NAFLD (P < .05 for each comparison). CONCLUSION: NAFLD was found in 42.5% of acute ischemic stroke patients. NAFLD might be associated with more severe stroke and worse outcome.